NSE BSE
sakar healthcare limited stock

SAKAR HEALTHCARE LIMITED Share Price

- - (%)
- NSE: SAKAR

SAKAR HEALTHCARE LIMITED Share Price Update

As of the latest trading session, SAKAR HEALTHCARE LIMITED share price is currently at 332.5, which is down by -23.60 from its previous closing. Today, the stock has fluctuated between 330.30 and 354.85. Over the past year, SAKAR HEALTHCARE LIMITED has achieved a return of 25.28 %. In the last month alone, the return has been 6.72 %. Read More...

SAKAR HEALTHCARE LIMITED Performance

Day Range

Low330.30 High354.85
332.50

52 Week Range

Low 249.10 High 479.00
332.50

SAKAR HEALTHCARE LIMITED Share Price

9539

SAKAR

img img img img
No Data Available

Open Price

354.85

Prev. Close

356.10

Volume (Shares)

57293.00

Total traded value

190.49

Upper Circuit

427.30

Lower Circuit

284.90

Note: The current prices & values are delayed, Login to your account for live updates.

SAKAR HEALTHCARE LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 569.17
PE Ratio (TTM) 61.92
Book Value / Share 120.65
Beta 1.03
ROE 8.48%
EPS (TTM) 5.37
Dividend Yield 0.00%
Net Profit Qtr (Cr) 3.12

SAKAR HEALTHCARE LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 43.06
Operating Expense 39.04
Net Profit 3.12
Net Profit Margin (%) 7.24
Earnings Per Share (EPS) 1.46
EBITDA 11.75
Effective Tax Rate (%) 34.79
Particulars DEC 2023 (Values in Cr)
Revenue 37.23
Operating Expense 34.44
Net Profit 2.07
Net Profit Margin (%) 5.56
Earnings Per Share (EPS) 0.98
EBITDA 9.23
Effective Tax Rate (%) 31.00
Particulars SEP 2023 (Values in Cr)
Revenue 34.08
Operating Expense 30.59
Net Profit 3.64
Net Profit Margin (%) 10.68
Earnings Per Share (EPS) 1.68
EBITDA 10.02
Effective Tax Rate (%) 12.53
Particulars JUN 2023 (Values in Cr)
Revenue 38.99
Operating Expense 36.55
Net Profit 2.84
Net Profit Margin (%) 7.28
Earnings Per Share (EPS) 1.46
EBITDA 10.55
Effective Tax Rate (%) 28.10
Particulars MAR 2023 (Values in Cr)
Revenue 40.65
Operating Expense 38.57
Net Profit 3.92
Net Profit Margin (%) 9.64
Earnings Per Share (EPS) 2.04
EBITDA 9.59
Effective Tax Rate (%) -0.77
Particulars MAR 2024 (Values in Cr)
Revenue 153.35
Operating Expense 140.63
Net Profit 11.67
Net Profit Margin (%) 7.61
Earnings Per Share (EPS) 5.64
EBITDA 41.54
Effective Tax Rate (%) 26.60
Particulars MAR 2023 (Values in Cr)
Revenue 133.36
Operating Expense 121.15
Net Profit 12.76
Net Profit Margin (%) 9.56
Earnings Per Share (EPS) 6.58
EBITDA 37.82
Effective Tax Rate (%) 24.40
Particulars MAR 2022 (Values in Cr)
Revenue 128.23
Operating Expense 111.39
Net Profit 15.24
Net Profit Margin (%) 11.88
Earnings Per Share (EPS) 8.77
EBITDA 31.58
Effective Tax Rate (%) 19.83
Particulars MAR 2021 (Values in Cr)
Revenue 94.74
Operating Expense 82.67
Net Profit 10.69
Net Profit Margin (%) 11.28
Earnings Per Share (EPS) 6.88
EBITDA 23.78
Effective Tax Rate (%) 19.25
Particulars MAR 2020 (Values in Cr)
Revenue 82.98
Operating Expense 72.77
Net Profit 9.62
Net Profit Margin (%) 11.59
Earnings Per Share (EPS) 6.40
EBITDA 21.56
Effective Tax Rate (%) 21.25
Particulars MAR 2023 (Values in Cr)
Book Value / Share 91.04
ROE % 8.48
ROCE % 8.85
Total Debt to Total Equity 0.70
EBITDA Margin 28.35
Particulars MAR 2022 (Values in Cr)
Book Value / Share 74.45
ROE % 13.49
ROCE % 12.05
Total Debt to Total Equity 0.60
EBITDA Margin 24.63
Particulars MAR 2021 (Values in Cr)
Book Value / Share 63.04
ROE % 11.88
ROCE % 13.07
Total Debt to Total Equity 0.33
EBITDA Margin 25.09
Particulars MAR 2020 (Values in Cr)
Book Value / Share 54.35
ROE % 11.83
ROCE % 14.68
Total Debt to Total Equity 0.20
EBITDA Margin 25.99
Particulars MAR 2023 (Values in Cr)
Book Value / Share 91.09
ROE % 8.48
ROCE % 8.85
Total Debt to Total Equity 0.70
EBITDA Margin 28.35
Particulars MAR 2022 (Values in Cr)
Book Value / Share 74.50
ROE % 13.49
ROCE % 12.05
Total Debt to Total Equity 0.60
EBITDA Margin 24.63
Particulars MAR 2021 (Values in Cr)
Book Value / Share 63.04
ROE % 11.89
ROCE % 13.07
Total Debt to Total Equity 0.33
EBITDA Margin 25.10
Particulars MAR 2020 (Values in Cr)
Book Value / Share 54.35
ROE % 12.57
ROCE % 15.91
Total Debt to Total Equity 0.18
EBITDA Margin 25.99
Particulars MAR 2019 (Values in Cr)
Book Value / Share 47.95
ROE % 10.86
ROCE % 15.75
Total Debt to Total Equity 0.18
EBITDA Margin 25.70
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 267.76
Total Liabilities 267.76
Total Equity 127.46
Share Outstanding 17118000
Price to Book Ratio 1.81
Return on Assets (%) 5.66
Return on Capital (%) 7
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.08
Total Assets 177.79
Total Liabilities 177.79
Total Equity 98.45
Share Outstanding 15618000
Price to Book Ratio 1.79
Return on Assets (%) 6.00
Return on Capital (%) 7.71
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.29
Total Assets 115.03
Total Liabilities 115.03
Total Equity 81.31
Share Outstanding 14961000
Price to Book Ratio 0.92
Return on Assets (%) 8.36
Return on Capital (%) 10.03
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.09
Total Assets 336.42
Total Liabilities 336.42
Total Equity 173.43
Share Outstanding 19040000
Price to Book Ratio 2.20
Return on Assets (%) 3.79
Return on Capital (%) 4.48
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 267.84
Total Liabilities 267.84
Total Equity 127.53
Share Outstanding 17118000
Price to Book Ratio 1.81
Return on Assets (%) 5.69
Return on Capital (%) 7.02
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.08
Total Assets 177.80
Total Liabilities 177.80
Total Equity 98.46
Share Outstanding 15618000
Price to Book Ratio 1.79
Return on Assets (%) 6.01
Return on Capital (%) 7.71
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.29
Total Assets 115.12
Total Liabilities 115.12
Total Equity 81.31
Share Outstanding 14961000
Price to Book Ratio 0.92
Return on Assets (%) 8.35
Return on Capital (%) 10.02
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.36
Total Assets 97.38
Total Liabilities 97.38
Total Equity 71.73
Share Outstanding 14961000
Price to Book Ratio 1.03
Return on Assets (%) 6.87
Return on Capital (%) 8.4
Particulars MAR 2023 (Values in Cr)
Net Income 16.87
Cash from Operations 37.60
Cash from Investing -74.37
Cash from Financing 41.09
Net change in Cash 0.06
Free Cash Flow 119.80
Particulars MAR 2022 (Values in Cr)
Net Income 19.00
Cash from Operations 35.52
Cash from Investing -90.37
Cash from Financing 54.62
Net change in Cash -0.05
Free Cash Flow 133.05
Particulars MAR 2021 (Values in Cr)
Net Income 13.23
Cash from Operations 15.30
Cash from Investing -46.83
Cash from Financing 32.03
Net change in Cash -0.22
Free Cash Flow 62.13
Particulars MAR 2020 (Values in Cr)
Net Income 12.22
Cash from Operations 21.63
Cash from Investing -22.40
Cash from Financing 3.48
Net change in Cash -0.06
Free Cash Flow 43.68
Particulars MAR 2023 (Values in Cr)
Net Income 16.87
Cash from Operations 37.60
Cash from Investing -74.37
Cash from Financing 41.09
Net change in Cash 0.06
Free Cash Flow 119.80
Particulars MAR 2022 (Values in Cr)
Net Income 19.00
Cash from Operations 35.59
Cash from Investing -90.40
Cash from Financing 54.56
Net change in Cash -0.05
Free Cash Flow 133.12
Particulars MAR 2021 (Values in Cr)
Net Income 13.24
Cash from Operations 15.31
Cash from Investing -46.83
Cash from Financing 32.03
Net change in Cash -0.21
Free Cash Flow 62.14
Particulars MAR 2020 (Values in Cr)
Net Income 12.22
Cash from Operations 21.56
Cash from Investing -22.33
Cash from Financing 3.48
Net change in Cash -0.07
Free Cash Flow 43.53
Particulars MAR 2019 (Values in Cr)
Net Income 9.23
Cash from Operations 17.53
Cash from Investing -24.90
Cash from Financing 8.77
Net change in Cash 0.00
Free Cash Flow 37.68
Company Name Price P/E P/B Market Cap 52 Week Low/High
SAKAR HEALTHCARE LIMITED 332.50 61.92 2.80 723.18 249.10 / 479.00
BLISS GVS PHARMA LTD 110.15 12.05 1.19 1155.28 77.65 / 148.95
CIPLA LTD 1485.15 28.17 4.49 119928.54 1028.00 / 1581.70
FERMENTA BIOTECH LIMITED 229.35 0.00 2.33 675.00 137.10 / 262.00
GLAXOSMITHKLINE PHARMA LT 2570.70 66.32 24.49 43549.21 1376.50 / 2759.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
SAKAR HEALTHCARE LIMITED 332.50 61.92 2.75 723.18 249.10 / 479.00
AMRUTAJAN HEALTH LTD 738.70 47.47 7.40 2135.63 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6349.65 106.48 22.29 15874.13 3730.00 / 7550.00
BLISS GVS PHARMA LTD 110.15 15.17 1.16 1155.28 77.65 / 148.95
ABBOTT INDIA LIMITED 27407.65 48.49 15.74 58241.26 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 338.50
  • 26 Days 329.40
  • 10 Days 335.20
  • 50 Days 330.00
  • 12 Days 334.20
  • 100 Days 345.10
  • 20 Days 329.80
  • 200 Days 328.20
352.70
PIVOT
First Resistance 377.90
Second Resistance 399.70
Third Resistance 424.90
First Support 330.90
Second Support 305.70
Third Support 283.90
RSI 58.26
MACD 4.81
Commodity Channel Index (CCI) 74.33
ADX 33.60
Williams % R -65.73

Over 1 Month

down

6.72

Over 3 Months

down

-7.21

Over 6 Months

down

-21.58

Over 1 Year

down

25.28

Over 3 Years

down

24.17

Over 5 Years

down

41.60

SAKAR HEALTHCARE LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

SAKAR HEALTHCARE LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
33.32
Promoter Holdings
53.15
FII
13.51
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Sanjay S Shah Shareholding of Promoter and Promoter Group 9908543.0 45.56
Tata Capital Healthcare Fund Ii Public Shareholding 2309910.0 10.62
Hbm Healthcare Investments (cayman) Ltd Public Shareholding 1500000.0 6.9
Cobra India (mauritius) Limited Public Shareholding 1439899.0 6.62
Shah Aarsh Shareholding of Promoter and Promoter Group 1307500.0 6.01
Subhash Phootarmal Rathod Public Shareholding 549512.0 2.53
Hi-tech Chemicals Limited Public Shareholding 400000.0 1.84
Ritaben Shah Shareholding of Promoter and Promoter Group 245000.0 1.13
Shah Ayushi Shareholding of Promoter and Promoter Group 100000.0 0.46

SAKAR HEALTHCARE LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About SAKAR HEALTHCARE LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by SAKAR HEALTHCARE LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Sakar Healthcare Ltd?

Answer Field

The share price of Sakar Healthcare Ltd for NSE is ₹ 332.5 and for BSE is ₹ 0.00.

What is the Market Cap of Sakar Healthcare Ltd?

Answer Field

The market cap of Sakar Healthcare Ltd for NSE is ₹ 5,69.17 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Sakar Healthcare Ltd?

Answer Field

The 52 Week High and Low of Sakar Healthcare Ltd for NSE is ₹ 479.00 and ₹ 249.10 and for BSE is ₹ 0.00 and ₹ 0.00.

How to Buy Sakar Healthcare Ltd share?

Answer Field

You can trade in Sakar Healthcare Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Sakar Healthcare Ltd?

Answer Field

The 1 year returns on the stock has been 25.28%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader